XML 22 R11.htm IDEA: XBRL DOCUMENT v3.20.2
Equity Method Investments
9 Months Ended
Sep. 30, 2020
Equity Method Investments and Joint Ventures [Abstract]  
Equity Method Investments Equity Method Investments
For each of the following investments, we have the ability to exercise significant influence over these investments based on certain governance provisions and our participation in the significant activities and decisions that impact the management and economic performance of the investments.

Equity method investments comprise the following as of the dates indicated:
September 30, 2020December 31, 2019
OwnershipInvestment AmountOwnershipInvestment Amount
Mattox (1)
79.0%$166 $— 
Amberjack – Series A / Series B
75.0% / 50.0%
395 
75.0% / 50.0%
426 
Mars71.5%156 71.5%161 
Bengal50.0%89 50.0%88 
Permian Basin50.0%88 50.0%91 
LOCAP41.48%12 41.48%
Explorer38.59%79 38.59%88 
Poseidon36.0%— 36.0%— 
Colonial16.125%28 16.125%30 
Proteus10.0%14 10.0%15 
Endymion10.0%18 10.0%18 
$1,045 $926 
(1) Mattox was acquired as part of the April 2020 Transaction. This interest has been accounted for on a prospective basis. See below for additional information.

We acquired a 79% interest in Mattox in the April 2020 Transaction. This investment qualifies for equity method accounting, as we have the ability to exercise significant influence but not control over this investment as of the acquisition date. Upon acquisition, we recorded SGOM’s historical carrying value of the equity interests transferred as a transaction between entities under common control, totaling $174 million. We recognize equity earnings for Mattox prospectively from the date of acquisition, and record the distributions from Mattox as a reduction to the equity method investment balance.

For the three and nine months ended September 30, 2020, distributions received from equity method investments were $142 million and $412 million, respectively, and for the three and nine months ended September 30, 2019 were $130 million and $341 million, respectively.

Unamortized differences in the basis of the initial investments and our interest in the separate net assets within the financial statements of the investees are amortized into net income over the remaining useful lives of the underlying assets. As of September 30, 2020 and December 31, 2019, the unamortized basis differences included in our equity investments are $86 million and $92 million, respectively. For the three and nine months ended September 30, 2020 the net amortization expense was $2 million and $6 million, respectively, and for the three and nine months ended September 30, 2019, the net amortization expense was $2 million and $4 million, respectively.

During the first quarter of 2018, the investment amount for Poseidon was reduced to zero due to distributions received that were in excess of our investment balance, and we, therefore, suspended the equity method of accounting for this investment. Further, we have no commitments to provide further financial support to Poseidon. As such, we have recorded excess distributions in Other income of $7 million and $25 million for the three and nine months ended September 30, 2020, respectively, and $8 million and $25 million for the three and nine months ended September 30, 2019, respectively. If our cumulative share of equity earnings becomes greater than the amount of distributions received, we will resume the equity method of accounting as long as the equity method investment balance remains greater than zero.

Earnings from our equity method investments were as follows during the periods indicated:
Three Months Ended September 30,Nine Months Ended September 30, 2020
2020201920202019
Mattox (1)
$15 $— $30 $— 
Amberjack28 31 86 94 
Mars33 35 92 93 
Bengal14 18 
Explorer (2)
20 33 27 
Colonial (2)
14 17 59 21 
Other (3)
16 12 
$109 $115 $330 $265 
(1) We acquired an interest in Mattox on April 1, 2020. The acquisition of this interest has been accounted for prospectively.
(2) We acquired additional interests in Explorer and Colonial in June 2019. The acquisition of these interests has been accounted for prospectively. Prior to the acquisition date, Explorer and Colonial were accounted for as Other investments without readily determinable fair values and were therefore carried at cost.
(3) Included in Other is the activity associated with our investments in Permian Basin, LOCAP, Proteus and Endymion.

The adoption of the revenue standard for the majority of our equity method investments followed the non-public business entity adoption date of January 1, 2019 for their stand-alone financial statements, with the exception of Mars and Permian Basin, which adopted on January 1, 2018. As a result of the adoption of the revenue standard on January 1, 2019, we recognized our proportionate share of Amberjack’s cumulative effect transition adjustments as a decrease to opening (deficit) equity in the amount of $9 million under the modified retrospective transition method.

Under the lease standard, the adoption date for our equity method investments will follow the non-public business entity adoption date of January 1, 2020 or 2021 for their stand-alone financial statements, with the exception of Permian Basin, which adopted on January 1, 2019. There was no material impact on the Partnership’s consolidated financial statements as a result of the adoption of the lease standard by our equity method investees.

We assess our equity method investments for impairment whenever changes in the facts and circumstances indicate a loss in value has occurred, if the loss is deemed to be other than temporary. Due to the continuing effects of the COVID-19 pandemic, we evaluated whether an impairment indicator existed as of September 30, 2020. Based on our current forecast and expectations of market conditions, we determined that there was no triggering event that required us to update our impairment evaluation of our equity method investments. However, if the facts and circumstances change in the near-term and indicate a loss in value that is other-than-temporary, we will re-evaluate whether the carrying amount of our equity method investments may not be recoverable.

Summarized Financial Information

The following tables present aggregated selected unaudited income statement data for our equity method investments on a 100% basis. However, during periods in which an acquisition occurs, the selected unaudited income statement data reflects activity from the date of the acquisition.

Three Months Ended September 30, 2020
Total revenues Total operating expenses Operating income Net income
Statements of Income
Mattox$22 $$19 $19 
Amberjack69 16 53 54 
Mars68 22 46 46 
Bengal19 10 10 
Explorer
75 42 33 25 
Colonial319 172 147 89 
Poseidon36 27 26 
Other (1)
53 30 23 20 
(1) Included in Other is the activity associated with our investments in Permian Basin, LOCAP, Proteus and Endymion.
Nine Months Ended September 30, 2020
Total revenues Total operating expenses Operating income Net income
Statements of Income
Mattox (1)
$44 $$38 $38 
Amberjack219 52 167 167 
Mars201 71 130 130 
Bengal51 24 27 27 
Explorer
251 132 119 91 
Colonial1,068 501 567 374 
Poseidon99 26 73 68 
Other (2)
167 91 76 68 
(1) Our interest in Mattox was acquired on April 1, 2020. Mattox’s total revenues, total operating expenses and operating income (on a 100% basis) for the nine months ended September 30, 2020 were $62 million, $9 million and $53 million, respectively.
(2) Included in Other is the activity associated with our investments in Permian Basin, LOCAP, Proteus and Endymion.

Three Months Ended September 30, 2019
Total revenues Total operating expenses Operating income Net income
Statements of Income
Amberjack$80 $18 $62 $62 
Mars82 32 50 50 
Bengal22 15 15 
Explorer 122 51 71 55 
Colonial 354 190 164 109 
Poseidon31 22 20 
Other (1)
44 21 23 21 
(1) Included in Other is the activity associated with our investments in Permian Basin, LOCAP, Proteus and Endymion.

Nine Months Ended September 30, 2019
Total revenues Total operating expenses Operating income Net income
Statements of Income
Amberjack$235 $54 $181 $182 
Mars212 80 132 133 
Bengal59 23 36 36 
Explorer (1)
159 64 95 73 
Colonial (2)
442 234 208 136 
Poseidon96 26 70 63 
Other (3)
130 76 54 47 
(1) Our additional interest in Explorer was acquired on June 6, 2019. Explorers total revenues, total operating expenses and operating income (on a 100% basis) for the nine months ended September 30, 2019 were $344 million, $145 million and $199 million, respectively.
(2) Our additional interest in Colonial was acquired on June 6, 2019. Colonials total revenues, total operating expenses and operating income (on a 100% basis) for the nine months ended September 30, 2019 were $1,050 million, $520 million and $530 million, respectively.
(3) Included in Other is the activity associated with our investments in Permian Basin, LOCAP, Proteus and Endymion.
Capital ContributionsWe make capital contributions for our pro-rata interest in Permian Basin to fund capital and other expenditures. For both the three and nine months ended September 30, 2020, we made no capital contributions, and for the three and nine months ended September 30, 2019, we made capital contributions of $3 million and $13 million, respectively.